William D. Foulkes
William D. Foulkes
Professor of Oncology, Medicine, and Human Genetics. McGill University
Verified email at mail.mcgill.ca - Homepage
Cited by
Cited by
Triple-negative breast cancer
WD Foulkes, IE Smith, JS Reis-Filho
New England journal of medicine 363 (20), 1938-1948, 2010
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes, IM Stefansson, PO Chappuis, LR Bégin, JR Goffin, N Wong, ...
JNCI: Journal of the National Cancer Institute 95 (19), 1482-1485, 2003
BRCA1 and BRCA2: 1994 and beyond
SA Narod, WD Foulkes
Nature Reviews Cancer 4 (9), 665-676, 2004
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 …
FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ...
PLoS med 7 (5), e1000279, 2010
Breast-Cancer Risk in Families with Mutations in PALB2
AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ...
New England Journal of Medicine 371 (6), 497-506, 2014
Familial adenomatous polyposis
P Galiatsatos, WD Foulkes
American journal of gastroenterology 101 (2), 385-398, 2006
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results
SE Plon, DM Eccles, D Easton, WD Foulkes, M Genuardi, MS Greenblatt, ...
Human mutation 29 (11), 1282-1291, 2008
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe, HT Lynch, P Ghadirian, N Tung, I Olivotto, E Warner, ...
Journal of Clinical Oncology 22 (12), 2328-2335, 2004
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation
A Finch, M Beiner, J Lubinski, HT Lynch, P Moller, B Rosen, J Murphy, ...
Jama 296 (2), 185-192, 2006
Gene-panel sequencing and the prediction of breast-cancer risk
DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ...
New England Journal of Medicine 372 (23), 2243-2257, 2015
Folate-binding protein is a marker for ovarian cancer
IG Campbell, TA Jones, WD Foulkes, J Trowsdale
Cancer research 51 (19), 5329-5338, 1991
Inherited susceptibility to common cancers
WD Foulkes
New England Journal of Medicine 359 (20), 2143-2153, 2008
Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes
EA Rakha, SE Elsheikh, MA Aleskandarany, HO Habashi, AR Green, ...
Clinical Cancer Research 15 (7), 2302-2310, 2009
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
M Tischkowitz, JS Brunet, LR Bégin, DG Huntsman, MCU Cheang, ...
BMC cancer 7 (1), 134, 2007
Is breast cancer the same disease in Asian and Western countries?
SPL Leong, ZZ Shen, TJ Liu, G Agarwal, T Tajima, NS Paik, K Sandelin, ...
World journal of surgery 34 (10), 2308-2324, 2010
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
A Eisen, J Lubinski, J Klijn, P Moller, HT Lynch, K Offit, B Weber, ...
Journal of clinical oncology 23 (30), 7491-7496, 2005
REVEL: an ensemble method for predicting the pathogenicity of rare missense variants
NM Ioannidis, JH Rothstein, V Pejaver, S Middha, SK McDonnell, ...
The American Journal of Human Genetics 99 (4), 877-885, 2016
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes, JS Brunet, IM Stefansson, O Straume, PO Chappuis, ...
Cancer research 64 (3), 830-835, 2004
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation
APM Finch, J Lubinski, P Møller, CF Singer, B Karlan, L Senter, B Rosen, ...
Journal of Clinical Oncology 32 (15), 1547, 2014
Triple-negative breast cancer: risk factors to potential targets
BP Schneider, EP Winer, WD Foulkes, J Garber, CM Perou, A Richardson, ...
Clinical Cancer Research 14 (24), 8010-8018, 2008
The system can't perform the operation now. Try again later.
Articles 1–20